GlassScriptPhysician profile
Seokhyun Jin
NPI 1245724335
$25,205.05
in general payments reported to CMS, 2019-2025
9 companies · $581 in 2025
The $581 reported for 2025 was more than what 81% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $21K · 2023: $1,324 · 2024: $2,785 · 2025: $581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,499 · Food and Beverage: $2,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,499.22 |
| Food and Beverage | $2,190.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $12,033.93 | 2022 | |
| Boston Scientific Corporation | $11,869.12 | 2022-2025 | Wavewriter Alpha Prime 16, Intracept, Spectra Wavewriter |
| Biotronik Nro, INC. | $900.37 | 2023-2025 | Prospera, Biotronik |
| Nevro Corp. | $141.33 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $115.63 | 2025 | Journavx |
| Curonix LLC | $61.41 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spinal Simplicity, LLC | $32.78 | 2024 | Ha Minuteman G3-R |
| Si-Bone, INC. | $28.75 | 2025 | |
| Painteq LLC | $21.73 | 2024 | Painteq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seokhyun Jin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.